Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dhaanya Seeds is a prominent Indian agricultural biotechnology brand specializing in the research, development, and commercialization of high-performance hybrid seeds. Originally established as the commercial face of Metahelix Life Sciences, the business was acquired by Crystal Crop Protection from Tata Chemicals in 2021. The company leverages advanced molecular breeding and biotechnology tools to produce superior seeds for key field crops including rice, maize, cotton, and pearl millet. Dhaanya focuses on improving crop yields and providing resistance against pests and environmental stressors for farmers across various agro-climatic zones. Its integrated R&D and distribution capabilities make it a significant player in the Indian agricultural sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dhaanya Seeds.